Denali Therapeutics Stock Filter Stocks by Fundamentals

DNLI Stock  USD 20.52  0.25  1.20%   
Denali Therapeutics fundamentals help investors to digest information that contributes to Denali Therapeutics' financial success or failures. It also enables traders to predict the movement of Denali Stock. The fundamental analysis module provides a way to measure Denali Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Denali Therapeutics stock.
The current Price To Sales Ratio is estimated to decrease to 8.47.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Denali Price to Sales Analysis

Denali Price to Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Denali Therapeutics is extremely important. It helps to project a fair market value of Denali Stock properly, considering its historical fundamentals such as Price to Sales. Since Denali Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Denali Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Denali Therapeutics' interrelated accounts and indicators.
0.910.990.490.96-0.75-0.790.430.640.930.930.940.90.980.660.80.590.930.150.930.820.69-0.280.85-0.84
0.910.910.210.91-0.53-0.890.570.530.890.920.960.790.910.590.870.370.930.010.910.780.82-0.350.94-0.84
0.990.910.460.98-0.71-0.820.50.580.940.910.950.820.980.720.820.590.930.090.910.820.7-0.330.85-0.81
0.490.210.460.44-0.760.01-0.250.070.290.210.290.510.530.220.130.540.42-0.090.440.66-0.20.140.14-0.36
0.960.910.980.44-0.69-0.810.510.560.940.910.950.80.960.570.820.590.930.080.910.810.7-0.310.85-0.81
-0.75-0.53-0.71-0.76-0.690.260.03-0.37-0.55-0.47-0.51-0.74-0.74-0.38-0.3-0.31-0.6-0.19-0.69-0.71-0.19-0.08-0.430.48
-0.79-0.89-0.820.01-0.810.26-0.83-0.41-0.93-0.87-0.9-0.59-0.78-0.6-0.86-0.44-0.840.1-0.79-0.64-0.930.69-0.940.8
0.430.570.5-0.250.510.03-0.83-0.030.720.50.580.190.410.40.570.120.47-0.090.510.340.84-0.910.74-0.52
0.640.530.580.070.56-0.37-0.41-0.030.480.760.590.710.560.380.540.490.540.50.480.240.440.230.41-0.41
0.930.890.940.290.94-0.55-0.930.720.480.90.930.760.910.620.840.560.890.040.880.750.84-0.580.92-0.86
0.930.920.910.210.91-0.47-0.870.50.760.90.970.840.890.580.890.590.910.190.860.680.81-0.290.87-0.82
0.940.960.950.290.95-0.51-0.90.580.590.930.970.780.930.670.90.570.950.050.90.780.8-0.370.91-0.84
0.90.790.820.510.8-0.74-0.590.190.710.760.840.780.860.420.660.490.820.290.850.730.57-0.090.72-0.8
0.980.910.980.530.96-0.74-0.780.410.560.910.890.930.860.630.770.60.97-0.030.940.90.65-0.290.86-0.82
0.660.590.720.220.57-0.38-0.60.40.380.620.580.670.420.630.620.420.550.030.510.450.47-0.290.53-0.53
0.80.870.820.130.82-0.3-0.860.570.540.840.890.90.660.770.620.540.780.070.670.540.73-0.320.76-0.9
0.590.370.590.540.59-0.31-0.440.120.490.560.590.570.490.60.420.540.59-0.130.40.480.18-0.140.35-0.52
0.930.930.930.420.93-0.6-0.840.470.540.890.910.950.820.970.550.780.59-0.130.940.910.71-0.350.91-0.8
0.150.010.09-0.090.08-0.190.1-0.090.50.040.190.050.29-0.030.030.07-0.13-0.130.05-0.290.140.3-0.07-0.04
0.930.910.910.440.91-0.69-0.790.510.480.880.860.90.850.940.510.670.40.940.050.910.75-0.390.93-0.76
0.820.780.820.660.81-0.71-0.640.340.240.750.680.780.730.90.450.540.480.91-0.290.910.49-0.340.8-0.68
0.690.820.7-0.20.7-0.19-0.930.840.440.840.810.80.570.650.470.730.180.710.140.750.49-0.670.91-0.67
-0.28-0.35-0.330.14-0.31-0.080.69-0.910.23-0.58-0.29-0.37-0.09-0.29-0.29-0.32-0.14-0.350.3-0.39-0.34-0.67-0.610.4
0.850.940.850.140.85-0.43-0.940.740.410.920.870.910.720.860.530.760.350.91-0.070.930.80.91-0.61-0.78
-0.84-0.84-0.81-0.36-0.810.480.8-0.52-0.41-0.86-0.82-0.84-0.8-0.82-0.53-0.9-0.52-0.8-0.04-0.76-0.68-0.670.4-0.78
Click cells to compare fundamentals

Denali Price to Sales Historical Pattern

Today, most investors in Denali Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Denali Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Denali Therapeutics price to sales as a starting point in their analysis.
   Denali Therapeutics Price to Sales   
       Timeline  
Competition

Denali Price To Sales Ratio

Price To Sales Ratio

8.47

As of now, Denali Therapeutics' Price To Sales Ratio is increasing as compared to previous years.
Based on the latest financial disclosure, the price to sales indicator of Denali Therapeutics is roughly 0.0null. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Price to Sales (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Denali Fundamentals

About Denali Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Denali Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Denali Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Denali Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Price To Sales Ratio 8.92  8.47 

Pair Trading with Denali Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Denali Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Denali Stock

  0.54CLVRW Clever Leaves HoldingsPairCorr
The ability to find closely correlated positions to Denali Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Denali Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Denali Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Denali Therapeutics to buy it.
The correlation of Denali Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Denali Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Denali Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Denali Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Denali Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Denali Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Denali Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Denali Therapeutics Stock:
Check out Denali Therapeutics Piotroski F Score and Denali Therapeutics Altman Z Score analysis.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Denali Stock analysis

When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Denali Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.06)
Revenue Per Share
2.406
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.09)
Return On Equity
(0.14)
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.